▶ 調査レポート

世界の関節リウマチ検査市場(~2028年):血清学的検査、関節リウマチ重症度検査/投薬モニタリング検査、画像検査

• 英文タイトル:Global Rheumatoid Arthritis Testing Market Insights, Forecast to 2028

Global Rheumatoid Arthritis Testing Market Insights, Forecast to 2028「世界の関節リウマチ検査市場(~2028年):血清学的検査、関節リウマチ重症度検査/投薬モニタリング検査、画像検査」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-18233
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、関節リウマチ検査のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
関節リウマチ検査のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
関節リウマチ検査の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
関節リウマチ検査のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの関節リウマチ検査の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の関節リウマチ検査の売上および2028年までの予測に焦点を当てています。

関節リウマチ検査のグローバル主要企業には、Abbott Laboratories、F. Hoffmann-La Roche、Beckman Coulter、Siemens Healthcare GmbH、Imaware、Augurex Life Sciences、Qiagen、Svar Life Science AB、Exagen、Aviva Systems Biology、Bio-Rad Laboratoriesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

関節リウマチ検査市場は、タイプとアプリケーションによって区分されます。世界の関節リウマチ検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
血清学的検査、関節リウマチ重症度検査/投薬モニタリング検査、画像検査

【アプリケーション別セグメント】
病院/クリニック、クリニック、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 関節リウマチ検査製品概要
- タイプ別市場(血清学的検査、関節リウマチ重症度検査/投薬モニタリング検査、画像検査)
- アプリケーション別市場(病院/クリニック、クリニック、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の関節リウマチ検査販売量予測2017-2028
- 世界の関節リウマチ検査売上予測2017-2028
- 関節リウマチ検査の地域別販売量
- 関節リウマチ検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別関節リウマチ検査販売量
- 主要メーカー別関節リウマチ検査売上
- 主要メーカー別関節リウマチ検査価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(血清学的検査、関節リウマチ重症度検査/投薬モニタリング検査、画像検査)
- 関節リウマチ検査のタイプ別販売量
- 関節リウマチ検査のタイプ別売上
- 関節リウマチ検査のタイプ別価格
・アプリケーション別市場規模(病院/クリニック、クリニック、その他)
- 関節リウマチ検査のアプリケーション別販売量
- 関節リウマチ検査のアプリケーション別売上
- 関節リウマチ検査のアプリケーション別価格
・北米市場
- 北米の関節リウマチ検査市場規模(タイプ別、アプリケーション別)
- 主要国別の関節リウマチ検査市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの関節リウマチ検査市場規模(タイプ別、アプリケーション別)
- 主要国別の関節リウマチ検査市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の関節リウマチ検査市場規模(タイプ別、アプリケーション別)
- 主要国別の関節リウマチ検査市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の関節リウマチ検査市場規模(タイプ別、アプリケーション別)
- 主要国別の関節リウマチ検査市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの関節リウマチ検査市場規模(タイプ別、アプリケーション別)
- 主要国別の関節リウマチ検査市場規模(トルコ、サウジアラビア)
・企業情報
Abbott Laboratories、F. Hoffmann-La Roche、Beckman Coulter、Siemens Healthcare GmbH、Imaware、Augurex Life Sciences、Qiagen、Svar Life Science AB、Exagen、Aviva Systems Biology、Bio-Rad Laboratories
・産業チェーン及び販売チャネル分析
- 関節リウマチ検査の産業チェーン分析
- 関節リウマチ検査の原材料
- 関節リウマチ検査の生産プロセス
- 関節リウマチ検査の販売及びマーケティング
- 関節リウマチ検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 関節リウマチ検査の産業動向
- 関節リウマチ検査のマーケットドライバー
- 関節リウマチ検査の課題
- 関節リウマチ検査の阻害要因
・主な調査結果

Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.
Market Analysis and Insights: Global Rheumatoid Arthritis Testing Market
The global Rheumatoid Arthritis Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Serological Tests accounting for % of the Rheumatoid Arthritis Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals and Clinics segment is altered to an % CAGR throughout this forecast period.
China Rheumatoid Arthritis Testing market size is valued at US$ million in 2021, while the North America and Europe Rheumatoid Arthritis Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Rheumatoid Arthritis Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rheumatoid Arthritis Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rheumatoid Arthritis Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rheumatoid Arthritis Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rheumatoid Arthritis Testing market.
Global Rheumatoid Arthritis Testing Scope and Market Size
Rheumatoid Arthritis Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Imaging Tests
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others
By Company
Abbott Laboratories
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthcare GmbH
Imaware
Augurex Life Sciences
Qiagen
Svar Life Science AB
Exagen
Aviva Systems Biology
Bio-Rad Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatoid Arthritis Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Serological Tests
1.2.3 Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
1.2.4 Imaging Tests
1.3 Market by Application
1.3.1 Global Rheumatoid Arthritis Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rheumatoid Arthritis Testing Market Perspective (2017-2028)
2.2 Rheumatoid Arthritis Testing Growth Trends by Region
2.2.1 Rheumatoid Arthritis Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Rheumatoid Arthritis Testing Historic Market Size by Region (2017-2022)
2.2.3 Rheumatoid Arthritis Testing Forecasted Market Size by Region (2023-2028)
2.3 Rheumatoid Arthritis Testing Market Dynamics
2.3.1 Rheumatoid Arthritis Testing Industry Trends
2.3.2 Rheumatoid Arthritis Testing Market Drivers
2.3.3 Rheumatoid Arthritis Testing Market Challenges
2.3.4 Rheumatoid Arthritis Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatoid Arthritis Testing Players by Revenue
3.1.1 Global Top Rheumatoid Arthritis Testing Players by Revenue (2017-2022)
3.1.2 Global Rheumatoid Arthritis Testing Revenue Market Share by Players (2017-2022)
3.2 Global Rheumatoid Arthritis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rheumatoid Arthritis Testing Revenue
3.4 Global Rheumatoid Arthritis Testing Market Concentration Ratio
3.4.1 Global Rheumatoid Arthritis Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Testing Revenue in 2021
3.5 Rheumatoid Arthritis Testing Key Players Head office and Area Served
3.6 Key Players Rheumatoid Arthritis Testing Product Solution and Service
3.7 Date of Enter into Rheumatoid Arthritis Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatoid Arthritis Testing Breakdown Data by Type
4.1 Global Rheumatoid Arthritis Testing Historic Market Size by Type (2017-2022)
4.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Type (2023-2028)
5 Rheumatoid Arthritis Testing Breakdown Data by Application
5.1 Global Rheumatoid Arthritis Testing Historic Market Size by Application (2017-2022)
5.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Rheumatoid Arthritis Testing Market Size (2017-2028)
6.2 North America Rheumatoid Arthritis Testing Market Size by Type
6.2.1 North America Rheumatoid Arthritis Testing Market Size by Type (2017-2022)
6.2.2 North America Rheumatoid Arthritis Testing Market Size by Type (2023-2028)
6.2.3 North America Rheumatoid Arthritis Testing Market Share by Type (2017-2028)
6.3 North America Rheumatoid Arthritis Testing Market Size by Application
6.3.1 North America Rheumatoid Arthritis Testing Market Size by Application (2017-2022)
6.3.2 North America Rheumatoid Arthritis Testing Market Size by Application (2023-2028)
6.3.3 North America Rheumatoid Arthritis Testing Market Share by Application (2017-2028)
6.4 North America Rheumatoid Arthritis Testing Market Size by Country
6.4.1 North America Rheumatoid Arthritis Testing Market Size by Country (2017-2022)
6.4.2 North America Rheumatoid Arthritis Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Rheumatoid Arthritis Testing Market Size (2017-2028)
7.2 Europe Rheumatoid Arthritis Testing Market Size by Type
7.2.1 Europe Rheumatoid Arthritis Testing Market Size by Type (2017-2022)
7.2.2 Europe Rheumatoid Arthritis Testing Market Size by Type (2023-2028)
7.2.3 Europe Rheumatoid Arthritis Testing Market Share by Type (2017-2028)
7.3 Europe Rheumatoid Arthritis Testing Market Size by Application
7.3.1 Europe Rheumatoid Arthritis Testing Market Size by Application (2017-2022)
7.3.2 Europe Rheumatoid Arthritis Testing Market Size by Application (2023-2028)
7.3.3 Europe Rheumatoid Arthritis Testing Market Share by Application (2017-2028)
7.4 Europe Rheumatoid Arthritis Testing Market Size by Country
7.4.1 Europe Rheumatoid Arthritis Testing Market Size by Country (2017-2022)
7.4.2 Europe Rheumatoid Arthritis Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rheumatoid Arthritis Testing Market Size (2017-2028)
8.2 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Type
8.2.1 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Rheumatoid Arthritis Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Application
8.3.1 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Rheumatoid Arthritis Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region
8.4.1 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rheumatoid Arthritis Testing Market Size (2017-2028)
9.2 Latin America Rheumatoid Arthritis Testing Market Size by Type
9.2.1 Latin America Rheumatoid Arthritis Testing Market Size by Type (2017-2022)
9.2.2 Latin America Rheumatoid Arthritis Testing Market Size by Type (2023-2028)
9.2.3 Latin America Rheumatoid Arthritis Testing Market Share by Type (2017-2028)
9.3 Latin America Rheumatoid Arthritis Testing Market Size by Application
9.3.1 Latin America Rheumatoid Arthritis Testing Market Size by Application (2017-2022)
9.3.2 Latin America Rheumatoid Arthritis Testing Market Size by Application (2023-2028)
9.3.3 Latin America Rheumatoid Arthritis Testing Market Share by Application (2017-2028)
9.4 Latin America Rheumatoid Arthritis Testing Market Size by Country
9.4.1 Latin America Rheumatoid Arthritis Testing Market Size by Country (2017-2022)
9.4.2 Latin America Rheumatoid Arthritis Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatoid Arthritis Testing Market Size (2017-2028)
10.2 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Type
10.2.1 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Rheumatoid Arthritis Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Application
10.3.1 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Rheumatoid Arthritis Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country
10.4.1 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Rheumatoid Arthritis Testing Introduction
11.1.4 Abbott Laboratories Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Details
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Rheumatoid Arthritis Testing Introduction
11.3.4 Beckman Coulter Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.3.5 Beckman Coulter Recent Developments
11.4 Siemens Healthcare GmbH
11.4.1 Siemens Healthcare GmbH Company Details
11.4.2 Siemens Healthcare GmbH Business Overview
11.4.3 Siemens Healthcare GmbH Rheumatoid Arthritis Testing Introduction
11.4.4 Siemens Healthcare GmbH Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.4.5 Siemens Healthcare GmbH Recent Developments
11.5 Imaware
11.5.1 Imaware Company Details
11.5.2 Imaware Business Overview
11.5.3 Imaware Rheumatoid Arthritis Testing Introduction
11.5.4 Imaware Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.5.5 Imaware Recent Developments
11.6 Augurex Life Sciences
11.6.1 Augurex Life Sciences Company Details
11.6.2 Augurex Life Sciences Business Overview
11.6.3 Augurex Life Sciences Rheumatoid Arthritis Testing Introduction
11.6.4 Augurex Life Sciences Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.6.5 Augurex Life Sciences Recent Developments
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Rheumatoid Arthritis Testing Introduction
11.7.4 Qiagen Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.7.5 Qiagen Recent Developments
11.8 Svar Life Science AB
11.8.1 Svar Life Science AB Company Details
11.8.2 Svar Life Science AB Business Overview
11.8.3 Svar Life Science AB Rheumatoid Arthritis Testing Introduction
11.8.4 Svar Life Science AB Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.8.5 Svar Life Science AB Recent Developments
11.9 Exagen
11.9.1 Exagen Company Details
11.9.2 Exagen Business Overview
11.9.3 Exagen Rheumatoid Arthritis Testing Introduction
11.9.4 Exagen Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.9.5 Exagen Recent Developments
11.10 Aviva Systems Biology
11.10.1 Aviva Systems Biology Company Details
11.10.2 Aviva Systems Biology Business Overview
11.10.3 Aviva Systems Biology Rheumatoid Arthritis Testing Introduction
11.10.4 Aviva Systems Biology Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.10.5 Aviva Systems Biology Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Rheumatoid Arthritis Testing Introduction
11.11.4 Bio-Rad Laboratories Revenue in Rheumatoid Arthritis Testing Business (2017-2022)
11.11.5 Bio-Rad Laboratories Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer